BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1767626)

  • 1. The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients.
    Driessen JJ; Vree TB; Guelen PJ
    Acta Anaesthesiol Belg; 1991; 42(3):149-55. PubMed ID: 1767626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.
    Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L
    Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients.
    Vree TB; Shimoda M; Driessen JJ; Guelen PJ; Janssen TJ; Termond EF; van Dalen R; Hafkenscheid JC; Dirksen MS
    Clin Pharmacol Ther; 1989 Nov; 46(5):537-44. PubMed ID: 2582710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of acute renal failure on FPIA rapid serum assay of midazolam and its main metabolite.
    Bouton V; Bourget P; Lesne-Hulin A; Amstutz P; Benayed M; Benhamou D; Dufieux JL; Goursot G; Grobuis S; Haberer JP; Jardin F; Kirstetter P; Marty J; Mercatello A; Page B; Pourriat JL; Vassal T
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):531-8. PubMed ID: 9401837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients.
    Malacrida R; Fritz ME; Suter PM; Crevoisier C
    Crit Care Med; 1992 Aug; 20(8):1123-6. PubMed ID: 1643892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetic monitoring of midazolam in critically ill patients.
    Spina SP; Ensom MH
    Pharmacotherapy; 2007 Mar; 27(3):389-98. PubMed ID: 17316150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam infusion for basal sedation in intensive care: absence of accumulation.
    Michalk S; Moncorge C; Fichelle A; Huot O; Servin F; Farinotti R; Desmonts JM
    Intensive Care Med; 1988; 15(1):37-41. PubMed ID: 3230199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
    Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
    Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous Midazolam infusion for sedation of respirator patients].
    Behne M; Asskali F; Steuer A; Förster H
    Anaesthesist; 1987 May; 36(5):228-32. PubMed ID: 3631490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients--preliminary results.
    Dirksen MS; Vree TB; Driessen JJ
    Anaesth Intensive Care; 1987 Nov; 15(4):440-4. PubMed ID: 3122596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?
    Oldenhof H; de Jong M; Steenhoek A; Janknegt R
    Clin Pharmacol Ther; 1988 Mar; 43(3):263-9. PubMed ID: 3345618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients.
    Boulieu R; Lehmann B; Salord F; Fisher C; Morlet D
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):255-8. PubMed ID: 9725490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of interrupted versus continuous sedative infusions in ventilated children.
    Gupta K; Gupta VK; Jayashree M; Singhi S
    Pediatr Crit Care Med; 2012 Mar; 13(2):131-5. PubMed ID: 21283046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
    Barr J; Donner A
    Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
    Riker RR; Shehabi Y; Bokesch PM; Ceraso D; Wisemandle W; Koura F; Whitten P; Margolis BD; Byrne DW; Ely EW; Rocha MG;
    JAMA; 2009 Feb; 301(5):489-99. PubMed ID: 19188334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propofol versus midazolam. Long-term sedation in the intensive care unit].
    Beyer R; Seyde WC
    Anaesthesist; 1992 Jun; 41(6):335-41. PubMed ID: 1636917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination.
    Richman PS; Baram D; Varela M; Glass PS
    Crit Care Med; 2006 May; 34(5):1395-401. PubMed ID: 16540957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Propofol-midazolam in continuous infusion for sedation in intensive care].
    Pappagallo S; Giannoni S; Romagnoli P; Viviani V; Tinacci S; Tulli G
    Minerva Anestesiol; 1993 Sep; 59(9):441-6. PubMed ID: 8278066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children.
    Bienert A; Bartkowska-Sniatkowska A; Wiczling P; Rosada-Kurasińska J; Grześkowiak M; Zaba C; Teżyk A; Sokołowska A; Kaliszan R; Grześkowiak E
    Pharmacol Rep; 2013; 65(1):107-21. PubMed ID: 23563029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.